NASDAQ: HCTIHealthcare Triangle Inc Stock
$0.20+0.00 (+0%)
Updated Apr 17, 2025
HCTI Price
$0.20
Fair Value Price
N/A
Market Cap
$9.22M
52 Week Low
$0.19
52 Week High
$1.90
P/E
-0.18x
P/B
-1.8x
P/S
0.45x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.70M
Earnings
-$5.97M
Gross Margin
24.7%
Operating Margin
-40.56%
Profit Margin
-51%
Debt to Equity
-1.38
Operating Cash Flow
-$1M
Beta
0.89
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HCTI Overview
Healthcare Triangle, Inc., a healthcare IT company, offers cloud and data science solutions, and professional and managed services. Its suite of software, solutions, platforms, and services enable healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, and collaborative research and development. The company's lead products are called CloudEz, DataEz, and Readabl.AI. Healthcare Triangle was incorporated in 2019 and is based in Pleasanton, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HCTI's potential to beat the market
- HCTI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
HCTI
RankedUnranked of 44
RankedUnranked of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important HCTI news, forecast changes, insider trades & much more!
HCTI News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HCTI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HCTI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HCTI is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
HCTI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more HCTI due diligence checks available for Premium users.
Valuation
HCTI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.18x
Industry
11.14x
Market
27.98x
HCTI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.8x
Industry
3.39x
HCTI's financial health
Profit margin
Revenue
$2.2M
Net Income
-$1.3M
Profit Margin
-61.6%
HCTI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HCTI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.0M
Liabilities
$7.1M
Debt to equity
-1.38
HCTI's short-term liabilities ($7.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HCTI's short-term assets ($1.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HCTI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HCTI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$811.0k
Investing
$0.0
Financing
$803.0k
HCTI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HCTI vs Health Information Service Stocks
Healthcare Triangle Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.